Navigation Links
GE Healthcare President & CEO, Mark Vachon, to Present at BioConference Live
Date:10/31/2009

Boston, MA, October 29, 2009 / b3c newswire /- PlatformQ, a digital media company that produces online events for the healthcare, education and energy markets, and LabRoots, a free social networking site serving the scientific community, today announced that Mark Vachon, the President and CEO for GE Healthcares Americas region, will speak at BioConference Live on Thursday November 19th at 2:00 PM.

GE Healthcare is interested in supporting new and innovative ways to reach out and engage with current and prospective customers, said Mark Vachon, President and CEO of GE Healthcare. BioConference Live allows us to meet this goal by giving us a platform to connect live with researchers, scientists and industry leaders online.

Since joining GE in 1982, Vachon has provided leadership in several of GEs businesses and most recently served as President and CEO of GE Healthcares Global Diagnostic Imaging business. Vachons focus is on leveraging the capabilities of GE Healthcare in partnering with governments and clinicians to lower costs, improve quality, and achieve greater access in healthcare.

BioConference Live will feature presentations and case studies on a wide range of topics, including cancer research, drug discovery and delivery, genetics and genome research, microbiology and lab automation. A complete list of speakers and session topics is available at BioConferenceLive.com.

BioConference Live offers all the benefits of a conventional physical conference, s
'/>"/>

b3c newswire

0

GOOD

Page: 1 2

Related biology news :

1. TGen Clinical Research Services at Scottsdale Healthcare and Mayo Clinic study new cancer drug
2. Phoenix conference highlights TGens and Scottsdale Healthcares contributions to molecular oncology
3. TGen, Scottsdale Healthcare, Mayo Clinic study new drug to stimulate immune system of cancer victims
4. Sangamo BioSciences to Present at the Bank of America 2008 Healthcare Conference
5. Hand hygiene initiative aims to decrease healthcare-associated infection in developing countries
6. Conference to examine role technology can play in helping US manage healthcare costs
7. 57 college presidents declare support for public access to publicly funded research in the US
8. IEEE-USA President endorses national innovation strategy
9. Science Coalition commends Presidents strategy for innovation
10. AMP president updates CDC committee on H1N1 testing
11. PNNL scientist garners early career presidential award

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...rs to understanding how sounds associated with Nav...l or if they hear it at all. , The same type of...ses to detect flaws in the space shuttle,s behemot... peek inside the giant head of a whale. The scans ...of a whale,s hearing anatomy using a breakthrough ...
(Date:11/24/2009)... of Medical Toxicology (ACMT) have signed an agree...rnal of Medical Toxicology (JMT), the official jo...s previously published by the University of Pennsy...ogy , an international, peer-reviewed journal, is ... medical toxicology. The quarterly journal focuse...
(Date:11/24/2009)...) New research on bacterial communities throughou...table temporal patterns, suggesting that scientist...oring climate change in the polar regions. The stu... National Academy of Sciences Early Edition, show...fted synchronously over time, correlating with sea...
Breaking Biology News(10 mins):Rocket science leads to new whale discovery 2Springer and the American College of Medical Toxicology to work together 2Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 1New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 2New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 3New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 4New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 5New Poll Shows Values Voters in Lockstep on the 26amp 3B 238216 3BMoral Implications 26apos 3B of Health Care Reform 57646 6Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 1Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 2Project Runway Designer in New Orleans to Educate About Living with HIV and Combat Stigma Associated with the Disease through Living Positive By Desig 57642 3AAA Members Save and Stay Healthy With Annual Eye Exams 57638 1AAA Members Save and Stay Healthy With Annual Eye Exams 57638 2AAA Members Save and Stay Healthy With Annual Eye Exams 57638 3
...Tulane National Primate Research Center has for th... agents in a vaginal gel protect the animals again... microbicide using compounds that inhibit the proc...ells could potentially provide a safe, effective a...men, according to study investigators. The study, ...
...anipulating the mosquitoes, sense of smell is the ...nderbilt University, that has been selected to rec...to Global Health. , The initiative, which was laun... just announced the selection of 43 "groundbreakin...ng countries that will receive a total of $436 mil...
...ty researchers have identified some of the key fac...d by multiple sclerosis (MS), complications of pre...he findings offer important clues about why the ne...ys that at least some forms of brain damage could ...st edition of the scientific journal Nature Medici...
Other Biology News:Vaginal gel may provide a new approach to HIV prevention 2Fighting malaria by manipulating mosquitoes' sense of smell 2Fighting malaria by manipulating mosquitoes' sense of smell 3Molecular Partners Required For Appropriate Neuronal Gene Repression 2Molecular Partners Required For Appropriate Neuronal Gene Repression 3Molecular Partners Required For Appropriate Neuronal Gene Repression 4
(Date:11/24/2009)..., CALGARY and BLENHEIM, Ontario, Nov. 24 /PRNews...ed today it is acquiring the assets of Hyland Seed...tario. The addition of Hyland Seeds will further e...the company anticipates the introduction of Smart...de Tolerant Trait Technology in corn in 2012. The ...
(Date:11/24/2009)... , REYKJAVIK, Iceland, November ... (Nasdaq: DCGN ) today announced the approval of a...cy Court for the District of Delaware,(the "Bankru...etition for,relief under Chapter 11 of the United ..., The orders issued by the Bankruptcy Cou...
(Date:11/24/2009)...SEATTLE,Nov.24/PRNewswire/--BlueMarbleEnergyCorp.a...opmentAuthority(OPDA)wererecentlyawarded$2millionb...oard(CERB)inaprivate/publicpartnershiptoconstructt...colnCounty,WA. ,, "Thisinvestmentwillsignifican...70greenjobstoLincolnCounty,"saidBlueMarbleEnergyCE...
(Date:11/24/2009)..., DUBLIN, November 24 /PRNewswire-FirstCall...obal specialty biopharmaceutical company, today,an...n Medicines Agency for,velaglucerase alfa, the com...or the treatment of Type 1 Gaucher disease. This i...e alfa that has been submitted, with previous,subm...
Breaking Biology Technology:Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 2Dow AgroSciences Canada Announces Agreement to Acquire Hyland Seeds 3deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 2deCODE genetics, Inc. Announces Approval of First Day Motions by Bankruptcy Court 3Blue Marble Energy, OPDA Awarded $2M by WA's Community Economic Revitalization Board 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 2Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 3Shire Submits European Marketing Authorization Application (MAA) for velaglucerase alfa for the Treatment of Type 1 Gaucher Disease 4
..., Aug. 19 Omeros Corporation, a,Seattle-based cli...h AS, a,Norwegian human antibody therapeutics comp...n agreement for the discovery and development of f...MASP-2, or mannan-binding,lectin-associated serine...,system via the lectin pathway and is linked to mu...
...olio of Transfusion Solutions Offers Choice, ...ROCKAWAY, N.J., Aug. 18 Biotest Diagnostics Corpo...based Biotest AG, a worldwide,supplier of traditio...s,that it has received final clearance from the U....keting its full line of traditional blood,bank rea...
... 4C Controls Inc. (OTCBB: FOUR.OB) today announc...(Ret.) Dr. Philip Hayden as its Vice President, Se... NEW YORK (Business Wire EON) A... after a distinguished career with the Federal Bur...years involved in many aspects of law enforcement ...
Other Biology Technology:Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 2Affitech and Omeros Enter Into Antibody Discovery and Development Agreement 3Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents 2Biotest Diagnostics Receives FDA Clearance for Full Line of Traditional Blood Bank Reagents 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 2 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 3 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis 4
10% BSA in TBS from Upstate
Rabbit Anti-Aortic Elastin Polyclonal Antibody, Unconjugated from Abcam
Anti-Mouse VEGF-C Antibody, Unconjugated from Raybiotech, Inc.
Rabbit Anti-MEF2A, phospho (Thr312) Antibody, Unconjugated from Spring Bioscience
Biology Products: